Table 1

Baseline characteristics of the total study population and cases only, stratified by sex

WomenMen
Study population (n=866 834)Cases (n=1659)Study population (n=821 451)Cases (n=3834)
CharacteristicsAge in years, median (IQR)49.3 (37.9–62.8)70.1 (59.2–78.8)48.2 (37.7–60.8)65.2 (56.4–74.6)
EthnicityDutch644 413 (74.3)1353 (81.6)610 862 (74.4)3164 (82.5)
Western102 123 (11.8)162 (9.8)91 508 (11.1)360 (9.4)
Antillean6794 (0.8)*6618 (0.8)20 (0.5)
Moroccan21 227 (2.4)20 (1.2)23 564 (2.9)33 (0.9)
Surinamese34 382 (4.0)68 (4.1)27 742 (3.4)117 (3.1)
Turkish19 575 (2.3)19 (1.1)21 219 (2.6)57 (1.5)
Miscellaneous non-Western38 320 (4.4)*39 938 (4.9)83 (2.2)
Income in euros, median (IQR)21 753 (16 221–29 432)18 367 (14 855.5–24 222)23 258 (17 331–31 132)20 844 (16 213–27 793)
Income quintiles†Q1159 075 (18.4)163 (9.8)178 574 (21.7)560 (14.6)
Q2164 660 (19.0)218 (13.1)173 005 (21.1)701 (18.3)
Q3170 208 (19.6)291 (17.5)167 367 (20.4)770 (20.1)
Q4183 494 (21.2)499 (30.1)154 227 (18.8)967 (25.2)
Q5189 397 (21.8)488 (29.4)148 278 (18.1)836 (21.8)
DeterminantsEmployment statusUnemployed167 707 (19.3)339 (20.4)86 297 (10.5)564 (14.7)
Employed508 418 (58.7)293 (17.7)589 213 (71.7)1325 (34.6)
Pensioner190 709 (22.0)1027 (61.9)145 941 (17.8)1945 (50.7)
Primary earner statusPrimary earner298 266 (34.4)634 (38.2)463 601 (56.4)2236 (58.3)
Equal earning110 311 (12.7)193 (11.6)223 079 (27.2)1048 (27.3)
Not primary earner458 257 (52.9)832 (50.2)134 771 (16.4)550 (14.3)
Living with childrenYes282 171 (32.6)155 (9.3)244 526 (29.8)476 (12.4)
No584 663 (67.4)1504 (90.7)576 925 (70.2)3358 (87.6)
Marital statusNot married227 684 (26.3)174 (10.5)272 656 (33.2)496 (12.9)
Married438 221 (50.6)857 (51.7)446 055 (54.3)2648 (69.1)
Divorced109 610 (12.6)239 (14.4)80 021 (9.7)465 (12.1)
Widowed91 293 (10.5)389 (23.4)22 697 (2.8)225 (5.9)
Missing26 (0.003)22 (0.003)
Living situationAlone551 967 (63.7)1097 (66.1)496 031 (60.4)2274 (59.3)
Together314 867 (36.3)562 (33.9)325 420 (39.6)1560 (40.7)
Metabolic factorsHypertension medication201 039 (23.2)1007 (60.7)160 780 (19.6)2064 (53.8)
Diabetes mellitus medication44 736 (5.2)304 (18.3)45 827 (5.6)588 (15.3)
Dyslipidaemia medication90 240 (10.4)506 (30.5)107 736 (13.1)1418 (37.0)
OutcomeFollow-up time in days, median (IQR)2556 (2556–2556)NA2556 (2556–2556)NA
Follow-up time in days, mean (SD)2395.717 (504.4625)NA2391.596 (510.9087)NA
CensoringOHCA1659 (0.2)NA3834 (0.5)NA
SCD817 (0.09)NA928 (0.1)NA
Other death63 810 (7.4)NA56 889 (6.9)NA
Unknown death1175 (0.1)NA1206 (0.1)NA
Moved37 420 (4.3)NA38 991 (4.7)NA
Administrative761 953 (87.9)NA719 603 (87.6)NA
  • Results are presented as n (%) unless indicated otherwise.

  • *Data are omitted to prevent revelation.

  • †Q1: €32 621–1 000 000; Q2: €25 152–32 620; Q3: €20 110–25 151; Q4: €15 527–20 109; Q5: €−500 000–15 526.

  • NA, not applicable; OHCA, out-of-hospital cardiac arrest; SCD, sudden cardiac death.